HHTM

RESEARCH TRIANGLE PARK, N.C. — New Phase 2 clinical data from Japan found that pediatric and adolescent and young adult (AYA) patients receiving PEDMARK® (sodium thiosulfate) following cisplatin chemotherapy experienced a significantly lower rate of hearing loss compared with a prespecified historical benchmark. Fennec Pharmaceuticals announced detailed results from the investigator-initiated STS-J01 study, which are being presented September 17 at

MILAN, ITALY — Amplifon is taking another step toward completing its proposed acquisition of GN Hearing, with the company’s Board of Directors moving to call a shareholders’ meeting to approve the issuance of 56 million new Amplifon shares to GN Store Nord as part of the transaction. The board approved a proposal for a capital increase reserved for GN, which

LYNGE, DENMARK — WSA has appointed Peter Bøggild as its new Chief Financial Officer and a member of the company’s Executive Board & Committee. Bøggild will join the hearing healthcare group no later than December 1, 2026. He succeeds Marianne Wiinholt, who stepped down at the end of August to pursue a portfolio of board and advisory roles. Bøggild joins

The people who share our lives are our most underused hearing tool—yet they often get no real coaching. When I leave my audiologist’s office with newly adjusted hearing aids, I feel cared for—the fit checked, my questions answered, the follow-up booked. But the conversations that decide whether those devices stay in my ears or land in a drawer happen elsewhere:

Oticon’s new Reveal hearing aid platform introduces a Dual AI approach designed to manage speech and contextual sounds while preserving the broader sound environment around the listener. Andrew Bellavia visits the Oticon Reveal U.S. launch at OticonNext in San Diego for an in-depth look at the technology with Michael Lamberson, President of Oticon USA, and Thomas Behrens, Vice President of

HANOVER, GERMANY — The international hearing care industry will gather in Hanover next month for the 70th International Congress of Hearing Aid Acousticians and its accompanying Industry Exhibition. The three-day event is scheduled for October 14–16, 2026, at Deutsche Messe Hannover. Organizers expect the anniversary event to bring together hearing care professionals, researchers, manufacturers, educators, students, and other industry participants

Editor’s note: Ear to the Ground is a monthly column from Dr. Brian Taylor, offering timely reflections on research, technology, clinical practice, and emerging trends in hearing care. You can read last month’s column here. Models, frameworks, and heuristics—all three terms describe similar things: simple guidelines, rules, or shortcuts used to solve a complex problem, better understand a concept, or

INNSBRUCK, AUSTRIA — MED-EL co-founder and CEO Dr. Ingeborg Hochmair has been named a recipient of the Honda Prize 2026, adding to a series of recent honors recognizing the scientists and engineers whose work contributed to the development of the modern cochlear implant. The announcement follows the selection of Hochmair and her husband and MED-EL co-founder, Dr. Erwin Hochmair, as recipients

BLUFFDALE, UTAH — Houses of worship in the United States and Europe are beginning to deploy Auri, the Auracast-based assistive listening system developed by Listen Technologies and Ampetronic, as churches look to expand audio accessibility for congregants. Recent installations include Christ Presbyterian Church in Edina, Minnesota; St. Gilbert Catholic Church in Grayslake, Illinois; and the Catholic Church in Unterbach, Switzerland.

NEW YORK — Nuance Audio, the hearing technology business of EssilorLuxottica, has introduced Nuance Audio Plus, the next generation of its over-the-counter hearing glasses, with updates aimed at improving amplification, speech clarity in noise, battery life and everyday usability. The new model builds on the original Nuance Audio Glasses, combining open-ear hearing technology with traditional eyewear for adults with perceived mild-to-moderate